A Phase II, Randomized, Double-Blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of the Efficacy and Safety of Recombinant Human Neuregulin-1 in Patients With Chronic Heart Failure
Gao, Runlin, MD, PhD, Zhang, Jian, MD, PhD, Cheng, Liuquan, MD, PhD, Wu, Xuesi, MD, PhD, Dong, Wei, MD, PhD, Yang, Xinchun, MD, PhD, Li, Tianchang, MD, PhD, Liu, Xifu, PhD, Xu, Yabei, MD, Li, Xinyan, MD, PhD, Zhou, Mingdong, PhD
Published in Journal of the American College of Cardiology (04.05.2010)
Published in Journal of the American College of Cardiology (04.05.2010)
Get full text
Journal Article